Lexington, MA, United States of America

Ann Barbier

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ann Barbier

Introduction: Ann Barbier, an accomplished inventor based in Lexington, MA, has made significant strides in the field of genetic therapies. With a total of six patents to her name, her work focuses on addressing rare genetic disorders, showcasing her dedication to improving patients' lives through innovative solutions.

Latest Patents: Among her latest patents is a groundbreaking invention titled "Composition and methods for treatment of ornithine transcarbamylase deficiency." This invention outlines methods for treating this condition by administering a composition containing mRNA encoding an ornithine transcarbamylase protein at specific doses and intervals, ultimately aiming to reduce the symptoms of the deficiency. Furthermore, her patent on the "Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of iduronate-2-sulfatase" provides crucial insights into combating cognitive issues related to Hunter syndrome. The method involves administering recombinant iduronate-2-sulfatase intrathecally to improve cognitive functions in affected individuals.

Career Highlights: Ann Barbier has built a strong career in the biotech industry, contributing her expertise to companies like Shire Human Genetic Therapies and Translate Bio. Her innovative work in genetic therapies has positioned her at the forefront of research and development aimed at tackling complex genetic conditions.

Collaborations: Throughout her career, Ann has collaborated with esteemed colleagues, including Thomas Mccauley and Charles W Richard, III. These partnerships have allowed her to expand the scope of her research and develop effective treatments through shared knowledge and resources.

Conclusion: Ann Barbier's contributions to genetic therapies exemplify her commitment to innovation and improvement in the healthcare landscape. With her six patents and ongoing collaborations, she continues to pave the way for advancements in the treatment of genetic disorders, making a lasting impact on the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…